These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1326115)

  • 21. Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
    Zalatnai A; Schally AV
    Int J Pancreatol; 1989 Mar; 4(2):149-60. PubMed ID: 2566638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
    Torres-Aleman I; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat.
    Rivier C; Vale W
    Endocrinology; 1990 Aug; 127(2):849-56. PubMed ID: 2115435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute N-methyl-D,L-aspartate administration stimulates the luteinizing hormone releasing hormone pulse generator in the ovine fetus.
    Bettendorf M; de Zegher F; Albers N; Hart CS; Kaplan SL; Grumbach MM
    Horm Res; 1999; 51(1):25-30. PubMed ID: 10095166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of dopaminergic mechanisms in mediating the central behavioral effects of morphine in rodents.
    Feigenbaum J; Yanai J
    Neuropsychobiology; 1984; 11(2):98-105. PubMed ID: 6090975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation.
    Koob GF; Swerdlow N; Seeligson M; Eaves M; Sutton R; Rivier J; Vale W
    Neuroendocrinology; 1984 Nov; 39(5):459-64. PubMed ID: 6096752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT
    Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of proline in position 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulation.
    Humphries J; Wan YP; Folkers K; Bowers CY
    Biochem Biophys Res Commun; 1976 Oct; 72(3):939-44. PubMed ID: 791291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties.
    Kostrzewa RM; Brus R; Coy DH; Criswell H; Coogan PS; Kastin AJ
    Pol J Pharmacol Pharm; 1992; 44(2):109-20. PubMed ID: 1357636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.
    Yano T; Pinski J; Radulovic S; Schally AV
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1701-5. PubMed ID: 8127868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone.
    Blank MS; Roberts DL
    Neuroendocrinology; 1982 Nov; 35(5):309-12. PubMed ID: 6755289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats.
    Debeljuk L; Torres-Alemán I; Schally AV
    Endocrinology; 1985 Jun; 116(6):2227-31. PubMed ID: 3158510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Culture sensitization and inhibition of luteinizing hormone responsive production of cyclic AMP in luteal cells by luteinizing hormone, prostaglandin F2 alpha and [D-Trp6]-luteinizing hormone releasing hormone.
    Hall AK; Behrman HR
    J Endocrinol; 1981 Jan; 88(1):27-38. PubMed ID: 6257819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible DA agonist properties of naloxone.
    Feigenbaum J; Yanai J; Blass R
    Int J Neurosci; 1982 Nov; 17(3):139-44. PubMed ID: 6302020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of a controlled-release microcapsule formulation of an LH-RH agonist (D-Trp-6-LH-RH) in the rhesus monkey menstrual cycle.
    Asch RH; Rojas FJ; Tice TR; Schally AV
    Int J Fertil; 1985; 30(2):19-26. PubMed ID: 2865220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acute central LH-RH administration of the skin temperature response in morphine dependent rats.
    Katovich MJ; Simpkins JW; O'Meara J
    Brain Res; 1989 Aug; 494(1):85-94. PubMed ID: 2670064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Physiol Behav; 1991 Oct; 50(4):825-30. PubMed ID: 1775558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.